• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550400-15
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Stenosis (2263); Test Result (2695)
Event Date 08/05/2020
Event Type  Injury  
Manufacturer Narrative
The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
Patient (b)(6).It was reported that on (b)(6) 2019, the patient presented with angina and a severely calcified, 70% stenosed lesion within the proximal left anterior descending (lad) coronary artery.Pre-dilatation and an atherectomy were performed.Following, a 4.0x15mm xience sierra stent (1550400-15, 8101641) was implanted without a device issue reported.The diameter stenosis was reduced to 0% with timi flow iii.On (b)(6) 2020, the patient was hospitalized for known in-stent restenosis which was being medically managed.A recent stress test revealed a small zone of reversibility in the inferior apex, suggesting mild ischemia.No additional information was provided regarding this issue.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.It should be noted that the reported patient effects of ischemia and stenosis are listed in the xience sierra, everolimus eluting coronary stent system instructions for use, as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined; however, the reported treatments appear to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
 
Manufacturer Narrative
Subsequent information revealed that there was no complaint against this xience sierra device.Based on the information reviewed, there remains no indication of a product quality issue with respect to manufacture, design or labeling.H6: result codes 213 and 114 removed.H6: conclusion codes 22 and 4311 removed.
 
Event Description
Subsequent to the previous medwatch report, the additional information was obtained: on (b)(6)2020, the patient presented for a renal transplant evaluation.A cardiac catheterization was performed revealing ostial left anterior descending (lad) and distal left main (lm) stenosis.There was a known ostial lad in-stent restenosis of an unspecified stent.Reportedly, the proximal lad 4.0x15mm xience sierra stent remained patent without a device malfunction.This new information revealed that there was no complaint against this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10479619
MDR Text Key205287043
Report Number2024168-2020-07281
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227493
UDI-Public08717648227493
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup,Followup
Report Date 11/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/01/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/21/2019
Device Model Number1550400-15
Device Catalogue Number1550400-15
Device Lot Number8101641
Was Device Available for Evaluation? No
Date Manufacturer Received10/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age70 YR
Patient Weight61
-
-